Invasive pulmonary aspergillosis caused by Aspergillus terreus diagnosed using virtual bronchoscopic navigation and endobronchial ultrasonography with guide sheath and successfully treated with liposomal amphotericin B
- 3 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Infection
- Vol. 49 (5), 1049-1054
- https://doi.org/10.1007/s15010-020-01545-x
Abstract
Invasive aspergillosis is a significant cause of mortality in patients with hematological malignancy. Early diagnosis of invasive pulmonary aspergillosis (IPA) by bronchoscopy is recommended but is often difficult to perform because of small lesion size and bleeding risk due to thrombocytopenia. A 71-year-old woman had received initial induction therapy for acute myeloid leukemia. On day 22 of chemotherapy, she had a high fever, and the chest computed tomography scan revealed a 20-mm-sized nodule with a halo sign. Bronchoscopy assisted by virtual bronchoscopic navigation (VBN) and endobronchial ultrasonography with a guide sheath (EBUS-GS) was performed, and Aspergillus terreus was identified from the culture of obtained specimens. A. terreus is often resistant to amphotericin B; thus, voriconazole is usually recommended for treatment. However, the obtained A. terreus isolate showed minimal inhibitory concentrations of 2 µg/mL for voriconazole and 0.5 µg/mL for amphotericin B. Therefore, the patient was successfully treated with liposomal amphotericin B. For patients suspected of having IPA, early diagnosis and drug susceptibility testing are very important. This case suggests that bronchoscopy using VBN and EBUS-GS is helpful for accurate diagnosis and successful treatment even if the lesion is small and the patient has a bleeding risk.Keywords
This publication has 21 references indexed in Scilit:
- High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumoniaJournal of Antimicrobial Chemotherapy, 2013
- Antifungal Susceptibility Testing: Clinical Laboratory and Standards Institute (CLSI) MethodsPublished by Springer Science and Business Media LLC ,2011
- Virtual bronchoscopic navigation combined with endobronchial ultrasound to diagnose small peripheral pulmonary lesions: a randomised trialThorax, 2011
- In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution MethodJournal of Clinical Microbiology, 2009
- AspergillosisThe New England Journal of Medicine, 2009
- Utility of Galactomannan Enzyme Immunoassay and (1,3) β- d -Glucan in Diagnosis of Invasive Fungal Infections: Low Sensitivity for Aspergillus fumigatus Infection in Hematologic Malignancy PatientsJournal of Clinical Microbiology, 2009
- Potential Basis for Amphotericin B Resistance in Aspergillus terreusAntimicrobial Agents and Chemotherapy, 2008
- Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo SignClinical Infectious Diseases, 2007
- Infections Due to Aspergillus terreus: A Multicenter Retrospective Analysis of 83 CasesClinical Infectious Diseases, 2004
- The Impact of Culture Isolation ofAspergillusSpecies: A Hospital‐Based Survey of AspergillosisClinical Infectious Diseases, 2001